-
B339979-5g2-(2-Bromoethoxy)ethanol.
-
D183030-1g3,6-Dioxaoctanedioic acid.
-
D183030-250mg3,6-Dioxaoctanedioic acid.
-
D183030-25g3,6-Dioxaoctanedioic acid.
-
D183030-5g3,6-Dioxaoctanedioic acid.
-
A163095-100mgNanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.
-
A163095-500mgNanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.
-
A163096-100mgNanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.
-
A163096-500mgNanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.
-
A163097-100mgNanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.
-
A163097-500mgNanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.
-
A163098-100mgNanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.